A pharmacist holds a package of EpiPens, made by the pharmaceutical company Mylan. CEO Heather Bresch will testify before the House Oversight and Government Reform Committee in the coming days after Mylan jacked up the price for the lifesaving drug by more than 500 percent since 2007.
A pharmacist holds a package of EpiPens, made by the pharmaceutical company Mylan. CEO Heather Bresch will testify before the House Oversight and Government Reform Committee in the coming days after Mylan jacked up the price for the lifesaving drug by more than 500 percent since 2007. Rich Pedroncelli The Associated Press
A pharmacist holds a package of EpiPens, made by the pharmaceutical company Mylan. CEO Heather Bresch will testify before the House Oversight and Government Reform Committee in the coming days after Mylan jacked up the price for the lifesaving drug by more than 500 percent since 2007. Rich Pedroncelli The Associated Press

Drug pricing is too complex to fix with Prop. 61

September 19, 2016 02:18 PM

UPDATED October 05, 2016 01:52 PM

More Videos

  • Around Donald Trump in the first 100 days

    Take a tour with Bee editorial cartoonist SW Parra of President Trump's up and downs during his first 100 days in office.